Author: FxConnectHUB
A passionate forex and crypto analyst sharing trading insights, strategies, and market news to help traders stay informed and make smarter financial decisions daily.
Citing a Trump administration official, the New York Times reported on Friday that the US Bureau of Labor Statistics (BLS) is calling back a limited number…
(RTTNews) – Asian stock markets are trading mostly lower on Friday, following the broadly negative cues from Wall Street overnight, as the markets remain concerned over…
Decentralized exchanges (DEX) registered $1.43 trillion in spot volume during the third quarter, marking the strongest quarterly performance on record and signaling a structural shift in…
Square Bitcoin Debuts as Block’s First Fully Integrated Bitcoin Payments and Wallet Solution
Block is expanding Square’s platform with fee-free bitcoin payments, seamless crypto conversions, and integrated financial tools designed to help merchants grow, diversify, and streamline operations. Square…
US BLS recalls staff to finish CPI report, prioritising Social Security and Fed timelines
BLS recalls staff to finish CPI report despite shutdown, aims to protect Social Security timeline.I had the earlier news on this here as it was hitting:Adding…
Sunset scene of light trails traffic speeds through an intersection in Gangnam center business district of Seoul at Seoul city, South KoreaMongkol Chuewong | Moment |…
It’s a battle of the comdolls! AUD/CAD is fast approaching a key technical resistance area on the 4-hour time frame. Will the pair stick to its…
Update (Oct. 9 at 7:15 pm UTC): This article has been updated to include a response from Peter Durant.A bill intended to establish a Bitcoin strategic…
Fed Governor Michael Barr said in a speech overnight that monetary policy remains “modestly restrictive”, and supported the decision to lower the federal funds rate by…
FDA Approves Celltrion’s EYDENZELT, Biosimilar To EYLEA, For Multiple Retinal Conditions
(RTTNews) – Celltrion Inc. announced that the U.S. Food and Drug Administration approved EYDENZELT (aflibercept-boav), biosimilar referencing EYLEA (aflibercept), for the treatment of neovascular (wet) age-related…
Risk Disclosure and Disclaimer for FXConnectHub.com
Trading financial instruments, including forex, stocks, commodities, and cryptocurrencies, involves a high level of risk and may not be suitable for all investors. The value of financial instruments can fluctuate significantly due to market volatility, economic events, regulatory actions, or political developments. You may sustain a loss of some or all of your invested capital. Trading on margin or using leverage can further amplify losses and increase your financial exposure.
Before engaging in any trading activity, carefully assess your investment goals, level of experience, and risk appetite. It is strongly recommended to seek advice from a licensed financial advisor if you are uncertain about the risks involved.
FXConnectHub.com provides content for informational and educational purposes only. While we strive to offer accurate, timely, and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any data presented on this website. Market data, prices, charts, and signals may not always be real-time or sourced from official exchanges. Such information is provided on an “as-is” basis and should not be used for trading or investment decisions.
FXConnectHub.com, its owners, contributors, and partners shall not be held responsible for any losses or damages incurred as a result of using the information provided on this website. Users assume full responsibility for their trading actions and outcomes.
We may receive compensation from affiliates, partners, and advertisers featured on this website. Compensation may influence the placement or visibility of certain content but does not affect our editorial integrity or objectivity.
By using this website, you acknowledge and agree to the terms of this disclaimer.
